Fact CheckerSign in

NCT07730047Not yet recruiting

NLR, ELR and SII Index as Biomarkers of Asthma Control

Neutrophil-to-Lymphocyte Ratio (NLR), Eosinophil-to-Lymphocyte Ratio (ELR), and Systemic Immune-Inflammation (SII) Index as Biomarkers of Asthma Control

Source: ClinicalTrials.gov · Last updated 28 Jul 2026

Brief summary (registry, in English)

This is Case control study aims to study Neutrophil-to-Lymphocyte Ratio (NLR), Eosinophil-to-Lymphocyte Ratio (ELR), and Systemic Immune Inflammation (SII) Index as Biomarkers of Asthma Controlin adult patients with bronchial asthma. This study will investigate the association between these inflammatory indices and the level of asthma control to assess their potential value as simple ,readily available and cost -effective biomarkers in clinical practice.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
140 (estimated)
First submitted
22 Jul 2026
Start date
1 Aug 2026
Primary completion date
1 Jan 2027
Lead sponsor
Shaimaa Ali Mohammed
Diseases
Asthma
NCT number
NCT07730047

What you commit to

  • Study type: Observational
  • Planned participants: 140
  • From 1 Aug 2026 to the primary completion date, 1 Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Acute respiratory infection within the previous 4 weeks.

Other illness

  • Patients with chronic respiratory diseases other than asthma.

Lab values

  • Patients with hematological disorders, malignancies, autoimmune diseases, or systemic inflammatory conditions that might affect blood cell counts.
  • Patients taking systemic steroids, experiencing acute asthma attack (because infection may affect neutrophil level).

Other

  • Pregnant women.

Who the study is looking for

  • Adult patients aged \> 18 years.
  • Confirmed diagnosis of bronchial asthma according to Global Initiative for Asthma (GINA) guidelines.
  • Patients who provided informed consent to participate in the study.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chest Department,Assiut University Hospital
Coordinator of this site? Confirm its status
AsyutEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.